# A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease.

> **NCT02585596** · PHASE2 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 275 (actual)

## Conditions studied

- Chronic Periodontitis

## Interventions

- **DRUG:** YH23537 1000mg/day
- **DRUG:** YH23537 2000mg/day
- **DRUG:** YH23537 3000mg/day
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02585596
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-16
- **Primary completion:** 2016-12-28
- **Final completion:** 2017-06-27
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02585596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02585596, "A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02585596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*